JP2018537949A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018537949A5 JP2018537949A5 JP2018513634A JP2018513634A JP2018537949A5 JP 2018537949 A5 JP2018537949 A5 JP 2018537949A5 JP 2018513634 A JP2018513634 A JP 2018513634A JP 2018513634 A JP2018513634 A JP 2018513634A JP 2018537949 A5 JP2018537949 A5 JP 2018537949A5
- Authority
- JP
- Japan
- Prior art keywords
- dendritic cell
- tnfα
- activated
- cells
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021186960A JP2022028818A (ja) | 2015-09-15 | 2021-11-17 | 進行したがんを有する被験体のための活性化樹状細胞組成物および免疫療法処置に関する方法 |
| JP2023200819A JP2024019229A (ja) | 2015-09-15 | 2023-11-28 | 進行したがんを有する被験体のための活性化樹状細胞組成物および免疫療法処置に関する方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562219058P | 2015-09-15 | 2015-09-15 | |
| US62/219,058 | 2015-09-15 | ||
| PCT/US2016/051781 WO2017048875A1 (en) | 2015-09-15 | 2016-09-14 | Methods relating to activated dendritic cell compositions and immunotherapeutic treatments for subjects with advanced cancers |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021186960A Division JP2022028818A (ja) | 2015-09-15 | 2021-11-17 | 進行したがんを有する被験体のための活性化樹状細胞組成物および免疫療法処置に関する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018537949A JP2018537949A (ja) | 2018-12-27 |
| JP2018537949A5 true JP2018537949A5 (https=) | 2019-10-31 |
| JP6980650B2 JP6980650B2 (ja) | 2021-12-15 |
Family
ID=58289879
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018513634A Active JP6980650B2 (ja) | 2015-09-15 | 2016-09-14 | 進行したがんを有する被験体のための活性化樹状細胞組成物および免疫療法処置に関する方法 |
| JP2021186960A Withdrawn JP2022028818A (ja) | 2015-09-15 | 2021-11-17 | 進行したがんを有する被験体のための活性化樹状細胞組成物および免疫療法処置に関する方法 |
| JP2023200819A Pending JP2024019229A (ja) | 2015-09-15 | 2023-11-28 | 進行したがんを有する被験体のための活性化樹状細胞組成物および免疫療法処置に関する方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021186960A Withdrawn JP2022028818A (ja) | 2015-09-15 | 2021-11-17 | 進行したがんを有する被験体のための活性化樹状細胞組成物および免疫療法処置に関する方法 |
| JP2023200819A Pending JP2024019229A (ja) | 2015-09-15 | 2023-11-28 | 進行したがんを有する被験体のための活性化樹状細胞組成物および免疫療法処置に関する方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20190046568A1 (https=) |
| EP (2) | EP3350318B1 (https=) |
| JP (3) | JP6980650B2 (https=) |
| KR (1) | KR20180044430A (https=) |
| CN (2) | CN108291204A (https=) |
| AU (2) | AU2016323066B2 (https=) |
| BR (1) | BR112018005180B1 (https=) |
| CA (1) | CA2998614A1 (https=) |
| DK (1) | DK3350318T3 (https=) |
| ES (1) | ES2923769T3 (https=) |
| HU (1) | HUE059560T2 (https=) |
| IL (3) | IL286225B2 (https=) |
| MX (2) | MX393996B (https=) |
| PL (1) | PL3350318T3 (https=) |
| RU (1) | RU2749610C2 (https=) |
| WO (1) | WO2017048875A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190076473A1 (en) * | 2017-09-14 | 2019-03-14 | Cellular Approaches, Inc. | Autologous and allogenic macrophages and monocytes for use in therapeutic methods |
| CN110106145B (zh) * | 2019-06-12 | 2021-02-12 | 蓝莲(杭州)生物科技有限公司 | 一种未成熟树突状细胞培养液及其未成熟树突状细胞的制备方法 |
| JP2022552200A (ja) * | 2019-10-07 | 2022-12-15 | ノースウエスト バイオセラピューティクス，インコーポレイティド | 樹状細胞およびＴ細胞の活性化を増強するためのならびにＴＨ－１免疫応答を誘導するためのｉｎ ｖｉｔｒｏの方法および組成物 |
| CN119286782B (zh) * | 2024-12-11 | 2025-04-04 | 上海赛笠百傲生物医药有限公司 | 一种高效诱导外周血来源单核细胞至不成熟树突状细胞的方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69333433T2 (de) | 1992-04-01 | 2004-12-02 | The Rockefeller University | Verfahren zur in vitro kultivierung dendritischer vorläuferzellen und deren verwendung zur immunogen herstellung |
| US7659119B2 (en) | 1996-02-12 | 2010-02-09 | Argos Therapeutics, Inc. | Method and compositions for obtaining mature dendritic cells |
| US6558951B1 (en) | 1999-02-11 | 2003-05-06 | 3M Innovative Properties Company | Maturation of dendritic cells with immune response modifying compounds |
| US20020094545A1 (en) | 2000-11-30 | 2002-07-18 | Harris Paul E. | Growth of human dendritic cells for cancer immunotherapy in closed system using microcarrier beads |
| AU2002326463A1 (en) | 2001-07-25 | 2003-02-17 | Northwest Biotherapeutics, Inc. | Methods and apparatus for enrichment and culture of monocytic dendritic cell precursors |
| CN1713951B (zh) | 2002-06-19 | 2010-05-26 | 西北生物治疗药物公司 | 切向流过滤设备和白细胞富集方法 |
| WO2004039968A1 (ja) * | 2002-10-30 | 2004-05-13 | Japan Science And Technology Agency | 骨髄由来の不死化樹状細胞株 |
| CN102600461B (zh) * | 2002-12-06 | 2017-07-14 | 西北生物治疗药物公司 | 给予体外部分成熟的树突细胞治疗肿瘤 |
| RU2364625C2 (ru) * | 2003-02-27 | 2009-08-20 | Норсуэст Байотерапьютикс, Инк. | Генерирование дендритных клеток из моноцитарных предшественников дендритных клеток с помощью gm-csf в отсутствие дополнительных цитокинов |
| US20060257359A1 (en) * | 2005-02-28 | 2006-11-16 | Cedric Francois | Modifying macrophage phenotype for treatment of disease |
| KR20220113543A (ko) * | 2005-12-08 | 2022-08-12 | 노쓰웨스트 바이오써라퓨틱스, 인크. | 미성숙 단핵구성 수지상 세포의 활성화를 유도하기 위한 조성물 및 방법 |
| US20100330057A1 (en) * | 2007-09-10 | 2010-12-30 | Riken | Method of evaluating human dentritic cells and human cell immunotherapeutic agent |
| EP2072617A1 (en) * | 2007-12-12 | 2009-06-24 | Trimed Biotech GmbH | Method for producing dendritic cells |
| CA3017298C (en) * | 2009-05-15 | 2021-09-28 | Irx Therapeutics, Inc. | Compositions comprising primary cell-derived biologics for enhancing immune responses in patients |
| CN103638517A (zh) * | 2013-12-04 | 2014-03-19 | 深圳市合一康生物科技有限公司 | 人树突状细胞疫苗制备的专用试剂盒 |
| WO2016048872A1 (en) * | 2014-09-23 | 2016-03-31 | Neostem Oncology, Llc | Compositions, methods and kits used to determine potency of dendritic cells in cancer immunitherpay |
-
2016
- 2016-09-14 RU RU2018113435A patent/RU2749610C2/ru active
- 2016-09-14 BR BR112018005180-2A patent/BR112018005180B1/pt active IP Right Grant
- 2016-09-14 IL IL286225A patent/IL286225B2/en unknown
- 2016-09-14 WO PCT/US2016/051781 patent/WO2017048875A1/en not_active Ceased
- 2016-09-14 IL IL313283A patent/IL313283B2/en unknown
- 2016-09-14 CA CA2998614A patent/CA2998614A1/en active Pending
- 2016-09-14 AU AU2016323066A patent/AU2016323066B2/en active Active
- 2016-09-14 MX MX2018003197A patent/MX393996B/es unknown
- 2016-09-14 HU HUE16847253A patent/HUE059560T2/hu unknown
- 2016-09-14 CN CN201680066721.XA patent/CN108291204A/zh active Pending
- 2016-09-14 KR KR1020187010610A patent/KR20180044430A/ko active Pending
- 2016-09-14 JP JP2018513634A patent/JP6980650B2/ja active Active
- 2016-09-14 EP EP16847253.8A patent/EP3350318B1/en active Active
- 2016-09-14 CN CN202211533672.XA patent/CN116413420A/zh active Pending
- 2016-09-14 EP EP21189488.6A patent/EP3971285A3/en active Pending
- 2016-09-14 ES ES16847253T patent/ES2923769T3/es active Active
- 2016-09-14 DK DK16847253.8T patent/DK3350318T3/da active
- 2016-09-14 US US15/759,699 patent/US20190046568A1/en active Pending
- 2016-09-14 PL PL16847253.8T patent/PL3350318T3/pl unknown
-
2018
- 2018-03-13 IL IL258071A patent/IL258071B/en unknown
- 2018-03-14 MX MX2022008806A patent/MX2022008806A/es unknown
-
2021
- 2021-11-17 JP JP2021186960A patent/JP2022028818A/ja not_active Withdrawn
-
2023
- 2023-07-27 AU AU2023208190A patent/AU2023208190B2/en active Active
- 2023-11-28 JP JP2023200819A patent/JP2024019229A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Weiner | The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides | |
| MacLeod et al. | Memory CD4 T cells: generation, reactivation and re‐assignment | |
| Araki et al. | The role of mTOR in memory CD8+ T‐cell differentiation | |
| Brunner et al. | Enhanced dendritic cell maturation by TNF-α or cytidine-phosphate-guanosine DNA drives T cell activation in vitro and therapeutic anti-tumor immune responses in vivo | |
| Santini et al. | The natural alliance between type I interferon and dendritic cells and its role in linking innate and adaptive immunity | |
| JP5730577B2 (ja) | 樹状細胞の作製方法 | |
| RU2005121256A (ru) | Введение дендритных клеток, подвергнутых частичному созреванию in vitro, для лечения опухолей | |
| Jelley‐Gibbs et al. | Influencing the fates of CD4 T cells on the path to memory: lessons from influenza | |
| EP1153122A2 (en) | Maturation of dendritic cells with immune response modifying compounds | |
| JP2016185956A (ja) | 寛容原性療法のための細胞のプログラミングの方法 | |
| Naoe et al. | Bacillus Calmette‐Guérin‐pulsed dendritic cells stimulate natural killer T cells and γδT cells | |
| JP2008000001A (ja) | 免疫刺激オリゴヌクレオチドおよびその医薬用途 | |
| JP2018537949A5 (https=) | ||
| McAleer et al. | Educating CD4 T cells with vaccine adjuvants: lessons from lipopolysaccharide | |
| JP2018523996A5 (https=) | ||
| AU2023208190B2 (en) | Methods relating to activated dendritic cell compositions and immunotherapeutic treatments for subjects with advanced cancers | |
| Choi et al. | The function of memory CD8+ T cells in immunotherapy for human diseases | |
| RU2018103235A (ru) | Оптимально активированные дендритные клетки, индуцирующие улучшенный или повышенный противоопухолевый иммунный ответ | |
| Moll | The role of dendritic cells at the early stages of Leishmania infection | |
| Schattenberg et al. | Response of human monocyte‐derived dendritic cells to immunostimulatory DNA | |
| Daudelin et al. | IL‐6 production by dendritic cells is dispensable for CD8+ memory T‐cell generation | |
| KR20220098351A (ko) | 수지상 세포 및 T 세포의 활성화를 증진시키고 Th-1 면역 반응을 유도하기 위한 시험관내 방법 및 조성물 | |
| JP2022552200A5 (https=) | ||
| EP1793678A1 (en) | Dendritic cell tumor injection (dcti) therapy | |
| JP5010280B2 (ja) | ヒトリンパ球由来のワクチンアジュバント |